Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 42 studies | 42% ± 19% | |
connective tissue cell | 15 studies | 37% ± 12% | |
pericyte | 13 studies | 20% ± 4% | |
endothelial cell | 13 studies | 26% ± 11% | |
adipocyte | 10 studies | 44% ± 18% | |
oligodendrocyte | 10 studies | 41% ± 12% | |
oligodendrocyte precursor cell | 9 studies | 27% ± 12% | |
smooth muscle cell | 9 studies | 27% ± 9% | |
endothelial cell of lymphatic vessel | 8 studies | 29% ± 11% | |
glutamatergic neuron | 8 studies | 45% ± 25% | |
astrocyte | 7 studies | 34% ± 18% | |
GABAergic neuron | 6 studies | 51% ± 22% | |
vein endothelial cell | 6 studies | 36% ± 16% | |
myofibroblast cell | 6 studies | 37% ± 10% | |
adventitial cell | 5 studies | 61% ± 5% | |
neuron | 3 studies | 30% ± 15% | |
placental villous trophoblast | 3 studies | 46% ± 31% | |
endothelial cell of artery | 3 studies | 28% ± 11% | |
chondrocyte | 3 studies | 41% ± 10% | |
interneuron | 3 studies | 71% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 98% | 12439.12 | 452 / 459 | 96% | 75.26 | 1068 / 1118 |
lung | 99% | 11190.26 | 573 / 578 | 84% | 27.03 | 971 / 1155 |
thymus | 100% | 11051.38 | 650 / 653 | 77% | 30.79 | 468 / 605 |
esophagus | 85% | 13760.31 | 1230 / 1445 | 79% | 27.87 | 145 / 183 |
intestine | 88% | 7736.90 | 847 / 966 | 72% | 25.41 | 378 / 527 |
bladder | 95% | 7921.48 | 20 / 21 | 56% | 15.56 | 283 / 504 |
uterus | 99% | 9346.59 | 168 / 170 | 49% | 13.07 | 226 / 459 |
skin | 82% | 35304.17 | 1484 / 1809 | 64% | 18.84 | 303 / 472 |
prostate | 83% | 5629.20 | 204 / 245 | 62% | 10.17 | 313 / 502 |
stomach | 57% | 4865.37 | 206 / 359 | 82% | 28.94 | 235 / 286 |
ovary | 100% | 15219.07 | 180 / 180 | 39% | 8.54 | 169 / 430 |
adrenal gland | 81% | 4086.78 | 209 / 258 | 52% | 8.25 | 120 / 230 |
adipose | 100% | 25037.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 17840.19 | 1332 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 7% | 285.76 | 22 / 328 | 92% | 59.56 | 163 / 178 |
heart | 92% | 11640.94 | 793 / 861 | 0% | 0 | 0 / 0 |
kidney | 21% | 952.20 | 19 / 89 | 62% | 15.66 | 558 / 901 |
spleen | 75% | 3797.60 | 180 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 19.90 | 28 / 45 |
lymph node | 0% | 0 | 0 / 0 | 48% | 7.22 | 14 / 29 |
brain | 5% | 158.38 | 128 / 2642 | 30% | 4.15 | 210 / 705 |
liver | 2% | 100.71 | 5 / 226 | 27% | 4.36 | 111 / 406 |
muscle | 28% | 1230.95 | 226 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 8% | 316.80 | 70 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.40 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035582 | Biological process | sequestering of BMP in extracellular matrix |
GO_1990314 | Biological process | cellular response to insulin-like growth factor stimulus |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0033627 | Biological process | cell adhesion mediated by integrin |
GO_0007507 | Biological process | heart development |
GO_2001205 | Biological process | negative regulation of osteoclast development |
GO_0007165 | Biological process | signal transduction |
GO_0001656 | Biological process | metanephros development |
GO_0035583 | Biological process | sequestering of TGFbeta in extracellular matrix |
GO_0048050 | Biological process | post-embryonic eye morphogenesis |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0001501 | Biological process | skeletal system development |
GO_0043010 | Biological process | camera-type eye development |
GO_0010467 | Biological process | gene expression |
GO_0048048 | Biological process | embryonic eye morphogenesis |
GO_0048286 | Biological process | lung alveolus development |
GO_0045671 | Biological process | negative regulation of osteoclast differentiation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0001527 | Cellular component | microfibril |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005604 | Cellular component | basement membrane |
GO_0030023 | Molecular function | extracellular matrix constituent conferring elasticity |
GO_0008201 | Molecular function | heparin binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0005179 | Molecular function | hormone activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005178 | Molecular function | integrin binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FBN1 |
Protein name | Fibrillin 1 Fibrillin-1 preproprotein Alternative protein FBN1 Fibrillin-1 [Cleaved into: Asprosin] |
Synonyms | FBN |
Description | FUNCTION: [Fibrillin-1]: Structural component of the 10-12 nm diameter microfibrils of the extracellular matrix, which conveys both structural and regulatory properties to load-bearing connective tissues . Fibrillin-1-containing microfibrils provide long-term force bearing structural support . In tissues such as the lung, blood vessels and skin, microfibrils form the periphery of the elastic fiber, acting as a scaffold for the deposition of elastin . In addition, microfibrils can occur as elastin-independent networks in tissues such as the ciliary zonule, tendon, cornea and glomerulus where they provide tensile strength and have anchoring roles . Fibrillin-1 also plays a key role in tissue homeostasis through specific interactions with growth factors, such as the bone morphogenetic proteins (BMPs), growth and differentiation factors (GDFs) and latent transforming growth factor-beta-binding proteins (LTBPs), cell-surface integrins and other extracellular matrix protein and proteoglycan components . Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively (By similarity). Negatively regulates osteoclastogenesis by binding and sequestering an osteoclast differentiation and activation factor TNFSF11 . This leads to disruption of TNFSF11-induced Ca(2+) signaling and impairment of TNFSF11-mediated nuclear translocation and activation of transcription factor NFATC1 which regulates genes important for osteoclast differentiation and function . Mediates cell adhesion via its binding to cell surface receptors integrins ITGAV:ITGB3 and ITGA5:ITGB1 . Binds heparin and this interaction has an important role in the assembly of microfibrils . .; FUNCTION: [Asprosin]: Adipokine secreted by white adipose tissue that plays an important regulatory role in the glucose metabolism of liver, muscle and pancreas . Hormone that targets the liver in response to fasting to increase plasma glucose levels . Binds the olfactory receptor OR4M1 at the surface of hepatocytes and promotes hepatocyte glucose release by activating the protein kinase A activity in the liver, resulting in rapid glucose release into the circulation . May act as a regulator of adaptive thermogenesis by inhibiting browning and energy consumption, while increasing lipid deposition in white adipose tissue (By similarity). Also acts as an orexigenic hormone that increases appetite: crosses the blood brain barrier and exerts effects on the hypothalamus (By similarity). In the arcuate nucleus of the hypothalamus, asprosin directly activates orexigenic AgRP neurons and indirectly inhibits anorexigenic POMC neurons, resulting in appetite stimulation (By similarity). Activates orexigenic AgRP neurons via binding to the olfactory receptor OR4M1 (By similarity). May also play a role in sperm motility in testis via interaction with OR4M1 receptor (By similarity). . |
Accessions | F6U495 P35555 ENST00000560355.1 H0YND0 Q75N89 L8E6V0 ENST00000316623.10 A0A6I8PL22 ENST00000674301.2 Q75N88 A0A1B1PFX5 ENST00000559133.6 H0YN80 L8E775 ENST00000537463.6 |